Differences in sars-cov-2-specific antibody responses after the first, second, and third doses of bnt162b2 in naïve and previously infected individuals: a 1-year observational study in healthcare professionals

HIGHLIGHTS

• who: Manca Ogri&ccaron from the Prevention (CDC), United States Taibah University, Saudi Arabia have published the article: Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Nau00efve and Previously Infected Individuals: A 1-Year Observational Study in Healthcare Professionals, in the Journal: (JOURNAL)
• what: The authors show that the high concentrations of anti-S antibodies were not protective against new variants of SARS-CoV-2, indicating the need to optimize vaccines for the different variants. vaccine does not effectively prevent the infection with the new . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.